• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强型乳腺磁共振成像的假阳性发现:BI-RADS 描述符研究。

False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.

机构信息

Institute of Diagnostic and Interventional Radiology, Friedrich-Schiller-University Jena, D-07740 Jena, Germany.

出版信息

AJR Am J Roentgenol. 2010 Jun;194(6):1658-63. doi: 10.2214/AJR.09.3486.

DOI:10.2214/AJR.09.3486
PMID:20489110
Abstract

OBJECTIVE

Breast MRI has high sensitivity in breast cancer detection, and the BI-RADS MRI lexicon was a step toward standardized description of lesions. However, false-positive findings occur and lead to unnecessary biopsy. The purpose of this investigation was to identify criteria for false-positive findings in clinical practice.

MATERIALS AND METHODS

Eligible for investigation were all breast MRI examinations from a consecutive 16-month time period that had histopathologic verification and findings classified as BI-RADS category 4-6 in the initial MRI report. Accordingly, 132 patients with 120 malignant and 31 benign lesions were enrolled. Two blinded observers categorized lesions into mass or nonmass and used BI-RADS to identify descriptor distribution differences between the benign and malignant subgroups.

RESULTS

The ratio of mass to nonmass lesions differed significantly (p < 0.001) between benign (1.2:1) and malignant (7:1) findings. Seventeen mass and 14 nonmass lesions were false-positive, and 105 mass and 15 nonmass lesions were true-positive. Among mass lesions, it was possible to differentiate malignant and benign lesions on the basis of margin (smooth, irregular, or spiculated) and dynamic enhancement features (p < 0.05). Among nonmass lesions, only stippled enhancement had a significant difference between the subgroups (p < 0.05). Tumor diameter had no influence on the correct diagnosis of nonmass lesions (p = 0.301). Conversely, among mass lesions, false-positive lesions were smaller than true-positive lesions (p = 0.01).

CONCLUSION

Nonmass lesions were the major cause of false-positive breast MRI findings. BI-RADS descriptors are not sufficient for differentiating benign and malignant nonmass lesions.

摘要

目的

乳腺 MRI 在乳腺癌检测中具有很高的敏感性,BI-RADS MRI 词汇是对病变进行标准化描述的一个步骤。然而,假阳性结果会出现,并导致不必要的活检。本研究的目的是确定临床实践中假阳性结果的标准。

材料和方法

符合调查条件的是所有在连续 16 个月的时间内进行的乳腺 MRI 检查,这些检查均有组织病理学验证,且在初始 MRI 报告中被归类为 BI-RADS 4-6 类别。因此,共有 132 名患者(120 例恶性和 31 例良性病变)入组。两名盲法观察者将病变分为肿块或非肿块,并使用 BI-RADS 来识别良性和恶性亚组之间描述符分布的差异。

结果

良性(1.2:1)和恶性(7:1)病变之间的肿块与非肿块病变的比例差异有统计学意义(p < 0.001)。17 个肿块和 14 个非肿块病变为假阳性,105 个肿块和 15 个非肿块病变为真阳性。在肿块病变中,基于边缘(光滑、不规则或分叶状)和动态增强特征可以区分良恶性病变(p < 0.05)。在非肿块病变中,只有点状增强在亚组之间有显著差异(p < 0.05)。肿瘤直径对非肿块病变的正确诊断没有影响(p = 0.301)。相反,在肿块病变中,假阳性病变比真阳性病变小(p = 0.01)。

结论

非肿块病变是导致乳腺 MRI 假阳性结果的主要原因。BI-RADS 描述符不足以区分良性和恶性非肿块病变。

相似文献

1
False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.增强型乳腺磁共振成像的假阳性发现:BI-RADS 描述符研究。
AJR Am J Roentgenol. 2010 Jun;194(6):1658-63. doi: 10.2214/AJR.09.3486.
2
BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.乳腺影像报告和数据系统(BI-RADS)病变特征可预测乳腺磁共振成像(MRI)中肿块的恶性可能性,但对非肿块样强化则不然。
AJR Am J Roentgenol. 2009 Oct;193(4):994-1000. doi: 10.2214/AJR.08.1983.
3
Characteristics of probably benign breast MRI lesions.可能为良性的乳腺MRI病变的特征。
AJR Am J Roentgenol. 2009 Sep;193(3):861-7. doi: 10.2214/AJR.08.2096.
4
Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.第五版 BI-RADS MRI 词汇表在乳腺成像中的观察者间变异性。
AJR Am J Roentgenol. 2015 May;204(5):1120-4. doi: 10.2214/AJR.14.13047.
5
MRI-detected suspicious breast lesions: predictive values of kinetic features measured by computer-aided evaluation.MRI检测出的可疑乳腺病变:计算机辅助评估测量的动力学特征的预测价值
AJR Am J Roentgenol. 2009 Sep;193(3):826-31. doi: 10.2214/AJR.08.1335.
6
Targeted ultrasound of the breast in women with abnormal MRI findings for whom biopsy has been recommended.针对MRI检查结果异常且已被建议进行活检的女性的乳腺靶向超声检查。
AJR Am J Roentgenol. 2009 Oct;193(4):1025-9. doi: 10.2214/AJR.09.2480.
7
Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI.乳腺 MRI 检查中疑似良性病变的恶性肿瘤发生率及影像学特征。
AJR Am J Roentgenol. 2015 Aug;205(2):442-7. doi: 10.2214/AJR.14.13530.
8
Use of dynamic phase subtraction (DPS) map in dynamic contrast-enhanced MRI of the breast.动态相位减法(DPS)图在乳腺动态对比增强磁共振成像中的应用。
J Comput Assist Tomogr. 2011 Nov-Dec;35(6):749-52. doi: 10.1097/RCT.0b013e318232fc6c.
9
Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.乳腺动态双侧对比增强磁共振成像:空间分辨率与时间分辨率之间的权衡
Radiology. 2005 Sep;236(3):789-800. doi: 10.1148/radiol.2363040811.
10
Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category.乳腺MRI在评估术后局部复发或新发乳腺癌中的应用:形态学及强化特征与乳腺影像报告和数据系统(BI-RADS)分类的相关性
Acta Radiol. 2007 Oct;48(8):838-45. doi: 10.1080/02841850701468883.

引用本文的文献

1
An Updated Systematic Review and Meta-Analysis of Diagnostic Accuracy of Dynamic Contrast Enhancement and Diffusion-Weighted MRI in Differentiating Benign and Malignant Non-Mass Enhancement Lesions.动态对比增强和扩散加权磁共振成像鉴别良性和恶性非肿块强化病变诊断准确性的最新系统评价和荟萃分析
J Clin Med. 2025 Jun 30;14(13):4628. doi: 10.3390/jcm14134628.
2
Preoperative Diagnosis of Ipsilateral and Contralateral Breast Cancer: Role of Diffusion-weighted MRI.同侧及对侧乳腺癌的术前诊断:扩散加权磁共振成像的作用
Radiology. 2025 Jun;315(3):e242423. doi: 10.1148/radiol.242423.
3
External validation of multiparametric magnetic resonance imaging-based decision rules for characterizing breast lesions and comparison to Kaiser score and breast imaging reporting and data system (BI-RADS) category.
基于多参数磁共振成像的乳腺病变特征描述决策规则的外部验证以及与凯泽评分和乳腺影像报告和数据系统(BI-RADS)分类的比较
Quant Imaging Med Surg. 2025 Jan 2;15(1):648-661. doi: 10.21037/qims-23-1783. Epub 2024 Dec 30.
4
Prognostic significance of total choline on in-vivo proton MR spectroscopy for prediction of late recurrence in patients with hormone receptor-positive, HER2-negative early breast cancer.总胆碱在体内质子磁共振波谱分析中对激素受体阳性、HER2阴性早期乳腺癌患者晚期复发预测的预后意义
PLoS One. 2025 Jan 2;20(1):e0311012. doi: 10.1371/journal.pone.0311012. eCollection 2025.
5
A risk prediction stratification for non-mass breast lesions, combining clinical characteristics and imaging features on ultrasound, mammography, and MRI.一种针对非肿块性乳腺病变的风险预测分层方法,结合了超声、乳腺X线摄影和MRI的临床特征及影像特征。
Front Oncol. 2024 Oct 17;14:1337265. doi: 10.3389/fonc.2024.1337265. eCollection 2024.
6
Breast lesions on MRI in mass and non-mass enhancement: Kaiser score and modified Kaiser score + for readers of variable experience.MRI上乳腺病变的肿块和非肿块强化:针对不同经验水平读者的凯泽评分和改良凯泽评分+
Eur Radiol. 2025 Jan;35(1):140-150. doi: 10.1007/s00330-024-10922-1. Epub 2024 Jul 11.
7
Ultrafast dynamic contrast-enhanced magnetic resonance imaging in distinguishing benign from malignant nonmass enhancement and excluding lesions that do not require treatment.超快动态对比增强磁共振成像在鉴别非肿块性强化的良恶性以及排除无需治疗的病变中的应用
Br J Radiol. 2024 Sep 1;97(1161):1588-1589. doi: 10.1093/bjr/tqae127.
8
The Role of MRI in Breast Cancer and Breast Conservation Therapy.磁共振成像在乳腺癌及保乳治疗中的作用
Cancers (Basel). 2024 Jun 1;16(11):2122. doi: 10.3390/cancers16112122.
9
Meta-analysis of dynamic contrast enhancement and diffusion-weighted MRI for differentiation of benign from malignant non-mass enhancement breast lesions.动态对比增强磁共振成像和扩散加权磁共振成像用于鉴别乳腺非肿块强化病变良恶性的Meta分析
Front Oncol. 2024 Mar 12;14:1332783. doi: 10.3389/fonc.2024.1332783. eCollection 2024.
10
Radiologic-Pathologic Correlation of Nonmass Enhancement Contiguous with Malignant Index Breast Cancer Masses at Preoperative Breast MRI.术前乳腺 MRI 中与恶性指数乳腺癌肿块相邻的非肿块样增强的放射-病理相关性。
Radiol Imaging Cancer. 2024 Mar;6(2):e230060. doi: 10.1148/rycan.230060.